In the present study, we identified a BC patient with a truncating variant in RAD54L. RNASEL, encoding the endoribonuclease RNase L, is a key enzyme in the interferon induced antiviral and anti-proliferate pathway (81, 82). Here, RNASEL is linked to breast cancer.